Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Jost

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Plos One|July 2, 2019
Mathematical models for cytarabine-derived myelosuppression in acute myeloid leukaemiaFelix Jost, Enrico Schalk, Kristine Rinke, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 23, 2026
Machine Learning Meets Pharmacokinetics: A Comparative Analysis of Predictive Models for Plasma Concentration-Time ProfilesFelix Jost, Clemens Giegerich, Christoph Grebner, et al.
IEEE Transactions on Bio-Medical Engineering|May 15, 2020
Model-Based Optimal AML Consolidation TreatmentFelix Jost, Enrico Schalk, Daniela Weber, et al.
Frontiers in Physiology|April 8, 2020
Model-Based Simulation of Maintenance Therapy of Childhood Acute Lymphoblastic LeukemiaFelix Jost, Jakob Zierk, Thuy T T Le, et al.
Mathematical Medicine and Biology : a Journal of the IMA|October 26, 2018
A mathematical model of white blood cell dynamics during maintenance therapy of childhood acute lymphoblastic leukemiaThuy T T Le, Felix Jost, Thomas Raupach, et al.
Journal of Cancer Research and Clinical Oncology|August 3, 2023
AML consolidation therapy: timing mattersAdrian-Manuel Reimann, Enrico Schalk, Felix Jost, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 8, 2021
The potent and selective RIPK2 inhibitor BI 706039 improves intestinal inflammation in the TRUC mouse model of inflammatory bowel diseaseJoerg Ermann, Mederbek Matmusaev, Emma K Haley, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Plos One|July 2, 2019
Mathematical models for cytarabine-derived myelosuppression in acute myeloid leukaemiaFelix Jost, Enrico Schalk, Kristine Rinke, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 23, 2026
Machine Learning Meets Pharmacokinetics: A Comparative Analysis of Predictive Models for Plasma Concentration-Time ProfilesFelix Jost, Clemens Giegerich, Christoph Grebner, et al.
IEEE Transactions on Bio-Medical Engineering|May 15, 2020
Model-Based Optimal AML Consolidation TreatmentFelix Jost, Enrico Schalk, Daniela Weber, et al.
Frontiers in Physiology|April 8, 2020
Model-Based Simulation of Maintenance Therapy of Childhood Acute Lymphoblastic LeukemiaFelix Jost, Jakob Zierk, Thuy T T Le, et al.
Mathematical Medicine and Biology : a Journal of the IMA|October 26, 2018
A mathematical model of white blood cell dynamics during maintenance therapy of childhood acute lymphoblastic leukemiaThuy T T Le, Felix Jost, Thomas Raupach, et al.
Journal of Cancer Research and Clinical Oncology|August 3, 2023
AML consolidation therapy: timing mattersAdrian-Manuel Reimann, Enrico Schalk, Felix Jost, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 8, 2021
The potent and selective RIPK2 inhibitor BI 706039 improves intestinal inflammation in the TRUC mouse model of inflammatory bowel diseaseJoerg Ermann, Mederbek Matmusaev, Emma K Haley, et al.
Pageof 1